Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Interim findings for phase IIb study of AeroLEF

Oct. 2, 2006

Recent patents report novel analgesic agents

Sep. 29, 2006

R&D highlights from the UBS Global Life Sciences Conference in New York: NeurogesX

Sep. 29, 2006

ACV-1 enters phase II for neuropathic pain

Sep. 29, 2006

Elan and Transition Therapeutics collaborate on AZD-103 for Alzheimer's

Sep. 29, 2006

Novel antioxidant compounds show benefit in a mouse model of amyotrophic lateral sclerosis

Sep. 28, 2006

Fampridine-SR meets all SPA efficacy criteria in MS walking study

Sep. 28, 2006

CytRx reports encouraging results from phase IIa ALS trial with arimoclomol

Sep. 28, 2006

Pagoclone advances for stuttering, discontinued for premature ejaculation

Sep. 28, 2006

Phase II results with FTY-720 in multiple sclerosis encourage phase III program

Sep. 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...